Haemonetics stock performance snapshot after recent weakness Haemonetics (HAE) has drawn investor attention after a period of share price weakness, with the stock down about 9% over the past month and ...

Blood products company Haemonetics (NYSE:HAE). reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales ...

Q4 FY26 earnings call recap: revenue/EPS, FY27 guidance, Persona PLUS momentum, IVT inflection, and tariff risks—read now.

Investors in Haemonetics Corporation HAE need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $40.00 Call had some of the highest ...

BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported a loss of $20.1 million in its fiscal fourth quarter. On a per-share basis, the Boston-based company said it had a loss of 44 ...

Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets ...

Blood products company Haemonetics (NYSE:HAE). will be announcing earnings results this Thursday before market hours. Here’s what to expect. Haemonetics beat analysts’ revenue expectations last ...

Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q1 2026 investor letter. A copy of the letter can be downloaded here. In Q1 2026, the Riverwater ...

Matson was the top performer as container shipping rates strengthened amid supply chain disruptions and management executed ...

A Yorkshire health technology company is preparing for international expansion after securing fresh investment to scale its ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Haemonetics , Scholar Rock Holding and Ocugen . Claim 55% Off TipRanks. Unlock hed ...

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.